Solid Biosciences Inc. SLDB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $46.14M+21.0% | $38.14M-1.9% | $38.86M+19.9% | $32.42M+4.9% | $30.91M+0.5% | ||
| $11.17M-0.9% | $11.27M+22.5% | $9.2M-0.9% | $9.28M+1.5% | $9.14M+0.1% | ||
| $57.31M+16.0% | $49.4M+2.8% | $48.06M+15.3% | $41.69M+4.1% | $40.05M+0.4% | ||
| -$57.31M-16.0% | -$49.4M-2.8% | -$48.06M-15.3% | -$41.69M-4.1% | -$40.05M-0.4% | ||
| —— | $0+100% | -$336K-660% | $60K-11.8% | $68K-9.3% | ||
| $571K— | $0-100% | $2.28M+3.1% | $2.21M+187% | $770K— | ||
| -$56.74M-14.0% | -$49.79M-8.8% | -$45.78M-15.9% | -$39.48M-0.5% | -$39.28M+7.8% | ||
| -$0.52+1.9% | -$0.53-10.4% | -$0.48-14.3% | -$0.42+28.8% | -$0.59+42.2% | ||
| -$56.91M-16.3% | -$48.94M-2.6% | -$47.68M-15.4% | -$41.31M-4.2% | -$39.65M-0.6% | ||
| -$57.31M-16.0% | -$49.4M-2.8% | -$48.06M-15.3% | -$41.69M-4.1% | -$40.05M-0.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Solid Biosciences Inc.'s revenue?
- Solid Biosciences Inc. (SLDB) generated $8.1M in revenue over the trailing twelve months, down 40.6% year over year.
- Is Solid Biosciences Inc. profitable?
- Solid Biosciences Inc. is not currently profitable: it reported a net loss of $191.8M over the trailing twelve months, a -1062.3% net margin.
- What is Solid Biosciences Inc.'s earnings per share?
- Solid Biosciences Inc.'s diluted EPS over the trailing twelve months is $-1.95.
- Where does Solid Biosciences Inc.'s income statement data come from?
- Every line is extracted from Solid Biosciences Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
